| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 135,710 | 132,467 | 124,253 | 147,090 | | Cost of Revenue | 34,819 | 35,533 | 33,337 | 41,662 | | | Gross Profit | 100,891 | 96,934 | 90,916 | 105,428 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 58,198 | 57,708 | 55,533 | 57,425 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,609 | 4,247 | 4,094 | 3,542 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,084 | 34,979 | 31,289 | 44,461 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 653 | 599 | (438) | 128 | | Earnings Before Interest And Taxes | 38,737 | 35,578 | 30,851 | 44,589 | | Interest Expense | 2,141 | 2,825 | 2,789 | 3,698 | | Income Before Tax | 36,596 | 32,753 | 28,062 | 40,891 | | Income Tax Expense | 13,948 | 12,991 | 11,373 | 16,304 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,648 | 19,762 | 16,689 | 24,587 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,648 | 19,762 | 16,689 | 24,587 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,648 | $19,762 | $16,689 | $24,587 |
|
0.63% Nasdaq 
0.03%
Income Statement
